MJ Insight

Explore MJ Insight, where we cover trending topics, provide industry insights, and keep you up-to-date on the latest compliance regulations.

Benefits+
Benefits+ | Compliance

Prescription Drug Reporting (RxDC Report)

The No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report information on prescription drugs and health care spending to the Departments of Labor (DOL), Health and (…)

There’s more to Read

We’re Sorry.

We could not find any Blogs for your specific search. Please try again.

Contact Us

We want to hear from you. Please visit us at one of our offices—or fill out our contact form.

Contact Us